Showing results for "#DCGI"
Norms for clearing foreign-made COVID-19 vaccines eased by DCGI
The decision by the Drugs Controller General of India (DCGI) comes in the backdrop of Pfizer and Cipla putting forth similar demands during...
Covovax approval to strengthen immunization efforts in India, lower...
Covovax is produced by Pune-based SII under licence from US-based vaccine maker Novavax Inc.
New drug Molnupiravir gets DCGI approval. Can it be the solution...
The Drug Controller General of India (DCGI) has given its nod to Molnupiravir for Emergency Use Authorisation (EUA) for the treatment of adult...
Centre refutes reports of administering expired Covid vaccines in...
This is false and misleading and based on incomplete information, the health ministry said in a statement.
Dr Reddy's to launch Molflu at Rs 35 per capsule for Covid treatment
Molflu will be priced at Rs 35 per capsule, a spokesperson of the Hyderabad-based drug maker said in a statement.
DCGI nod for Bharat Biotech’s nasal dose
Earlier, the Hyderabad-based manufacturer has proposed the booster dose for those who have been already been innoculated against COVID with Covishield...
Regular market approval to Covishield, Covaxin expected soon after...
Recently, the National Pharmaceutical Pricing Authority (NPPA), DCGI, Drug regulators and senior officials of the Union Health Ministry conducted a...
DCGI grants market approval for Covishield, Covaxin, to be available...
DCGI grants conditional market approval for Covishield and Covaxin